A novel high throughput screening platform reveals an optimised cytokine formulation for human hematopoietic progenitor cell expansion.
The main limitations of hematopoietic cord blood (CB) transplantation, viz. low cell dosage and delayed reconstitution, can be overcome by ex-vivo expansion. CB expansion under conventional culture causes the rapid cell differentiation and depletion of hematopoietic stem/progenitor cells (HSPC) resp...
Κύριοι συγγραφείς: | Tarunina, M, Hernandez, D, Kronsteiner-Dobramysl, B, Pratt, P, Watson, T, Hua, P, Gullo, F, Van der Garde, M, Zhang, Y, Hook, L, Choo, Y, Watt, S |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
Mary Ann Liebert, Inc
2016
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Single-cell assessment of transcriptome alterations induced by Scriptaid in early differentiated human haematopoietic progenitors during ex vivo expansion
ανά: Hua, P, κ.ά.
Έκδοση: (2019) -
Cryopreservation of hematopoietic stem/progenitor cells for therapeutic use.
ανά: Watt, S, κ.ά.
Έκδοση: (2007) -
Tailored Cytokine Optimization for ex vivo Culture Platforms Targeting the Expansion of Human Hematopoietic Stem/Progenitor Cells
ανά: André Branco, κ.ά.
Έκδοση: (2020-09-01) -
Increasing complexity of molecular landscapes in human hematopoietic stem and progenitor cells during development and aging
ανά: Watt, SM, κ.ά.
Έκδοση: (2022) -
An improved medium formulation for efficient ex vivo gene editing, expansion and engraftment of hematopoietic stem and progenitor cells
ανά: Rajeev Rai, κ.ά.
Έκδοση: (2023-06-01)